Feed REN.AS
RE

RELX PLC REN.AS · AMS

35.36 € -0.67% (-0.24 €)

Summary

69 / 100 · Bulios Score

What speaks for it

  • Out of every 100 GBP of revenue, 22 GBP is left as net profit.
  • It earns 22 GBP a year on every 100 GBP of invested capital.
  • It has raised its dividend 5 years in a row and pays out only 56% of profit.
  • It bought back its own shares for £1.58B in the last fiscal year, 3.0% of its market value.

What to watch

  • It missed profit estimates 6 times in the last 7 quarters.
  • For every 100 GBP of shareholders' equity it carries 310 GBP of debt.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Current price 35.36 €
P/E today 25.1
Specialty Business Services industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 25.1 GBP for 1 GBP of yearly profit.

Valuation in detail

Is it growing?

Slowly

Revenue (GBP)

Diluted EPS (GBP)

  • Analyst estimate

Revenue grew by 6.2% a year over 5 years. Over the last 3 years it grew by 3.9% a year. For the next fiscal year analysts expect revenue to grow by 6.5%. Earnings per share grew by 9.6% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 GBP of revenue goes

Net profit, industry median (Specialty Business Services) 6.9 GBP

Out of every 100 GBP of revenue, 23 GBP is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 3.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, stretched
Yield
2.24%
Paid out of profit
56%
Raised in a row
5 years

You receive 0.80 € per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

67% of the analysts recommend buying.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.